Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Upgrades
Updated: Monday, June 8, 2026 7:19:26 AM
Date
Broker
Company
Symbol
To
From
Target
4/30/19
Wedbush
Varonis Systems Inc.
VRNS
Outperform
Neutral
$85 Up From $55
4/4/19
WBB Securities
ADMA Biologics Inc
ADMA
Buy
Speculative Buy
$11.50
3/29/19
WBB Securities
Marker Therapeutics, Inc
MRKR
Strong Buy
Buy
$12.50 Up From $5.50
3/26/19
William Blair
Vertex Pharmaceuticals Inc.
VRTX
Outperform
Market Perform
N/A
3/22/19
Wedbush
Chipotle Mexican Grill Inc.
CMG-B
Neutral
Underperform
$640 Up From $500
3/12/19
WBB Securities
RedHill Biopharma Ltd.
RDHL
Buy
Speculative Buy
$17
1/24/19
Wedbush
Palo Alto Networks, Inc.
PANW
Outperform
Neutral
$265 Up From $225
1/17/19
Wedbush
Five Prime Therapeutics
FPRX
Outperform
Neutral
$16
12/28/18
Wedbush
Wingstop Inc
WING
Outperform
Neutral
$69 Down From $71
12/21/18
Wedbush
Signature Bank
SBNY
Outperform
Neutral
$125
12/11/18
Jefferies
Sanofi SA
SNY
Buy
Hold
€90 Up From €75
11/28/18
William Blair
Ooma, Inc.
OOMA
Outperform
Market Perform
N/A
11/21/18
Wedbush
Best Buy Co Inc.
BBY
Neutral
Underperform
$65
11/9/18
Wedbush
Karyopharm Therapeutics Inc.
KPTI
Outperform
Neutral
$19
11/7/18
Wedbush
Spark Therapeutics
ONCE
Neutral
Underperform
$40
11/2/18
Wedbush
Ansys Inc
ANSS
Outperform
Neutral
$184 Up from $180
11/1/18
Wedbush
Roku, Inc.
ROKU
Outperform
Neutral
$65 Down From $73
11/1/18
Wedbush
Walker & Dunlop, Inc.
WD
Outperform
Neutral
$55 Down From $58
10/29/18
Wedbush
Lennar Corp.
LEN
Outperform
Neutral
$50 Down From $56
10/26/18
Wedbush
Tractor Supply Co
TSCO
Outperform
Neutral
$100 Up From $80
10/23/18
Wedbush
VF Corp
VFC
Outperform
Neutral
$94
10/19/18
William Blair
Syneos Health, Inc.
SYNH
Outperform
Market Perform
N/A
10/17/18
WBB Securities
Kadmon Holdings Inc.
KDMN
Hold
Sell
$2.90
10/15/18
Wedbush
Arbutus Biopharma Corp.
ABUS
Neutral
Underperform
$
10/12/18
Wedbush
Fitbit Inc
FIT
Outperform
Neutral
$6.50
9/20/18
WBB Securities
Arcturus Therapeutics Holdings Inc.
ARCT
Strong Buy
Buy
$23
9/11/18
Wedbush
Snap Inc.
SNAP
Outperform
Neutral
$12.25 Up From $11.50
9/11/18
Canaccord
Nike Inc
NKE
Buy
Hold
$95 Up From $78
9/4/18
Wedbush
Fifth Third Bancorp
FITB
Outperform
Neutral
$34 Up From $31
8/20/18
William Blair
Flir Systems Inc.
FLIR
Outperform
Market Perform
N/A
8/10/18
William Blair
Ceridian HCM Holding Inc.
CDAY
Outperform
Market Perform
N/A
7/30/18
Wedbush
The Habit Restaurants Inc
HABT
Outperform
Neutral
$15 Up From $10
7/5/18
Canaccord
Hexcel Corp.
HXL
Buy
Hold
$80 Up From $70
7/2/18
William Blair
Curtiss-Wright Corp.
CW
Outperform
Market Perform
N/A
6/28/18
Wedbush
BOK Financial Corp.
BOKF
Outperform
Neutral
$112.0
6/18/18
Wedbush
Cherry Hill Mortgage Investment Corporation
CHMI
Outperform
Neutral
$19.50
6/11/18
WBB Securities
Arcturus Therapeutics Holdings Inc.
ARCT
Buy
Hold
$20
6/8/18
William Blair
Quest Diagnostics
DGX
Outperform
Market Perform
N/A
6/7/18
Wedbush
Wingstop Inc
WING
Outperform
Neutral
$59 Up From $51
6/1/18
Wedbush
Navient Corp.
NAVI
Outperform
Neutral
$15.75 Up From $14.50
Buy this Content
Editors Pick
Nuvalent Stock Climbs 39% On $10.6 Bln Takeover Deal With GSK
June 09, 2026 08:05 ET
OpenAI Joins IPO Race With Confidential S-1 Filing
June 09, 2026 05:10 ET
Tate & Lyle Stock Up On $3.6 Bln Cash Deal To Be Bought By Ingredion
June 08, 2026 07:11 ET
SpaceX Aims To Raise Around $75 Bln In IPO, Musk May Become World's First Trillionaire
June 04, 2026 07:12 ET